MRESVIA, injectable dispersion in a pre-filled syringe. mRNA vaccine contre respiratory syncytial virus syringe, 0.5 ml
Active ingredients: ARNM SIMPLE BRIN, À COIFFE EN 5', CODANT POUR LA GLYCOPROTÉINE F DU VRS-A, STABILISÉE DANS SA CONFORMATION DE PRÉFUSION
Commercialized according to BDPMDispensing in France: Prescription only
Injectable dispersionsyringe, 0.5 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MRESVIA, dispersion injectable en seringue préremplie. Vaccin à ARNm contre le virus respiratoire syncytial
- Pharmaceutical form
- dispersion injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 seringue préremplie copolymère de cyclooléfines (COC) de 0,5 mL dans une alvéole en carton
- Marketing authorisation holder
- MODERNA BIOTECH SPAIN SL (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Dec 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
64933425CIP73030218CIP133400930302187Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ARNM SIMPLE BRIN, À COIFFE EN 5', CODANT POUR LA GLYCOPROTÉINE F DU VRS-A, STABILISÉE DANS SA CONFORMATION DE PRÉFUSIONdispersion | 50 microgrammes · une dose de 0,5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.